FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:2095-2096 December 30, 1999 Number 27 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hochman, J. S. PubMed Citation

To the Editor: Hochman et al. (Aug. 26 issue)¹ reported the results of a randomized clinical trial in which they compared early revascularization with medical management in patients who had cardiogenic shock after an acute myocardial infarction. They did not find a statistically significant difference in mortality between the groups at 30 days. Mortality at six months, however, was significantly lower in the revascularization group.

A survival advantage at 30 days would have implied salvage of ischemic myocardium by revascularization that led to early improvement in left ventricular pump function. In this study, the authors' failure to show improvement in . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.